This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ResApp Health Past Earnings Performance

Past criteria checks 0/6

Key information

-0.5%

Earnings growth rate

4.9%

EPS growth rate

Healthcare Services Industry Growth42.6%
Revenue growth rate93.9%
Return on equity-1,029.0%
Net Margin-186.2%
Last Earnings Update30 Jun 2022

Recent past performance updates

Recent updates

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Dec 31
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Aug 26
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

May 08
Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Feb 25
Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

Dec 23
Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

Revenue & Expenses Breakdown
Beta

How ResApp Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:RAP Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 224-756
31 Mar 223-745
31 Dec 210-745
30 Sep 210-745
30 Jun 211-744
31 Mar 211-745
31 Dec 200-845
30 Sep 200-836
30 Jun 200-837
31 Mar 200-736
31 Dec 190-626
30 Sep 190-626
30 Jun 190-526
31 Mar 190-617
31 Dec 180-717
30 Sep 180-716
30 Jun 180-726
31 Mar 180-635
31 Dec 170-634
30 Sep 170-864
30 Jun 170-1083
31 Mar 170-1073
31 Dec 160-972
30 Sep 160-651
30 Jun 160-321
31 Mar 160-321
31 Dec 150-221
30 Sep 150-110

Quality Earnings: RAP is currently unprofitable.

Growing Profit Margin: RAP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RAP is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year.

Accelerating Growth: Unable to compare RAP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RAP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (1.4%).


Return on Equity

High ROE: RAP has a negative Return on Equity (-1028.99%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.